WASHINGTON -- Bone marrow transplants are one of cancer care's striking successes, but they have a dark side: The transplanted cells can turn on patients, attacking their skin and organs. The ...

DUBLIN--(BUSINESS WIRE)--The "Bone Marrow Transplant Rejection - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.This latest disease pipeline guide ...

A larger number of platelet transfusions given before a bone marrow transplant to treat bone marrow failure syndromes correlates with a greater risk of transplant rejection. A model system in mice ...

NEW YORK, March 28, 2017 /PRNewswire/ -- Bone Marrow Transplant Rejection - Pipeline Review, H1 2017 SummaryGlobal Markets Direct's latest Pharmac ...

Transplant patients may avoid rejection drugs. ... The treatment involved weakening the patient's immune system, then giving the recipient bone marrow from the person who donated the organ.

In this study of combined HLA-mismatched bone marrow and kidney transplantation in five patients, we were able to discontinue all immunosuppressive therapy in four patients, and they have retained ...

Blood cancers: Half-matched donor bone marrow transplant may be as good as full match. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2015 / 10 / 151007084531.htm ...

Five patients were alive 799, 387, 268, 196, and 130 days after bone marrow transplantation, with Patients 1, 4, 5, and 6 having been taken off all immunosuppressive therapy and Patient 7 ...